XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.4
SEGMENT INFORMATION
12 Months Ended
Sep. 30, 2021
SEGMENT INFORMATION  
SEGMENT INFORMATION

13.    SEGMENT INFORMATION

The Company operates in two principal segments - research services and research products. The Services segment provides research and development support on a contract basis directly to pharmaceutical companies. The Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. The accounting policies of these segments are the same as those described in the summary of significant accounting policies found in Note 2.

(a)    Operating Segments

Fiscal Year Ended September 30, 

    

2021

    

2020

Revenue:

 

  

 

  

Service

$

85,832

$

57,177

Product

 

3,773

 

3,292

$

89,605

$

60,469

Operating Income (Loss)

 

 

Service

$

13,986

$

8,210

Product

 

202

 

(437)

Unallocated corporate

 

(19,806)

 

(10,836)

$

(5,618)

$

(3,063)

 

 

Interest expense

 

(1,683)

 

(1,490)

Other income

 

13,420

 

15

Income (loss) before income taxes

$

6,119

$

(4,538)

As of September 30,

Fiscal Year Ended September 30, 

    

2021

    

2020

    

    

    

2021

    

2020

Identifiable assets:

 

  

 

  

 

Depreciation and amortization:

 

  

 

  

Services

 

$

161,805

 

$

54,480

 

Services

 

$

5,320

 

$

3,272

Products

1,772

1,535

 

Products

34

23

Unallocated corporate

158,279

5,578

 

Unallocated corporate

914

779

 

$

321,856

 

$

61,593

 

  

 

$

6,268

 

$

4,074

 

  

Goodwill, net:

 

Capital expenditures:

Services

 

$

51,927

 

$

4,368

 

Services

 

$

12,241

 

$

4,781

Products

 

Products

28

9

Unallocated corporate

 

Unallocated corporate

203

1,410

 

$

51,927

 

$

4,368

 

  

 

$

12,472

 

$

6,200

(b)    Geographic Information

Fiscal Year Ended September 30, 

    

2021

    

2020

Sales to External Customers:

 

  

 

  

United States

 

$

85,272

 

$

56,253

Other North America

143

148

Pacific Rim

2,040

2,826

Europe

1,795

1,207

Other

355

35

 

$

89,605

 

$

60,469

All of the Company’s long-lived assets are located in the United States and are included in the consolidated balance sheets for the years ended September 30, 2021 and 2020.

(c)    Major Clients

Sales are predominately to customers located principally in the United States. The Company extends trade credit to its customers on terms that are generally practiced in the industry. As of and for the years ended September 30, 2021 and 2020, no customers accounted for more than 10 percent of sales or accounts receivable.